Description: In collaboration with the Society of Actuaries Research Institute, RGA’s Behavioral Science team designed two experiments with U.S.-based participants to explore how behavioral science techniques can improve comprehension in life insurance purchasing journeys. The first experiment aimed to increase understanding of term life insurance via simulated online digital journeys. Building on the findings of the first, the second experiment investigated the effects of using both human and AI-generated videos. While the research focused on digital delivery of term life insurance, the relevance of tested techniques extends further, providing insights for improving information presentation for other insurance products and in non-digital formats.

Description: Interview on opportunities for InsurTechs in Life and Health reinsurance. Themes covered include digital distribution and digital health data. The article also shares insights into the role of the reinsurer when working with InsurTechs.

Description: Read the Quo Vadis Reinsurance.

Description: Description and welcome to the 2020 Canadian Reinsurance Conference including highlight of the key note speaker

Description: New digital data known as alternative data is everywhere. Our industry has seen the financial, and hi-tech industries leverage new digital data to expand their key offerings and core services. From the lens of the global life and health industry, new digital data is still searching to be further understood. Risk assessment is a current focus area for using alternative data. A key question is even though risk assessment has always been data-driven, can it now move to the next level with the arrival of this alternative data. Can we use alternative data to make the risk assessment process quicker, cheaper, or faster thereby driving more sales and better conversion rates. It is an exciting time! With the increased adoption of health and well-being apps, data such as physical activity, nutrition, sleep, and mental wellness is now readily available. Expanded data such as digital biomarkers, IoT data, electronic health records and many more can also be accessed. However, how to effectively implement alternative data remains a challenge across the industry. We firmly believe it is, and will continue to be, imperative to take a structured approach to alternative data through a set of key considerations and a framework of principles.